Brandes Investment Partners LP Lowers Stock Position in Phibro Animal Health Corporation $PAHC

Brandes Investment Partners LP trimmed its holdings in Phibro Animal Health Corporation (NASDAQ:PAHC) by 22.6% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 375,375 shares of the company’s stock after selling 109,379 shares during the quarter. Brandes Investment Partners LP owned approximately 0.93% of Phibro Animal Health worth $9,587,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Nuveen LLC acquired a new position in Phibro Animal Health in the first quarter valued at $10,312,000. Invesco Ltd. grew its holdings in shares of Phibro Animal Health by 92.3% during the first quarter. Invesco Ltd. now owns 387,739 shares of the company’s stock worth $8,282,000 after buying an additional 186,087 shares during the last quarter. Millennium Management LLC increased its position in Phibro Animal Health by 74.3% in the 1st quarter. Millennium Management LLC now owns 362,030 shares of the company’s stock valued at $7,733,000 after acquiring an additional 154,281 shares during the period. Russell Investments Group Ltd. raised its stake in Phibro Animal Health by 711.1% during the 1st quarter. Russell Investments Group Ltd. now owns 122,600 shares of the company’s stock valued at $2,619,000 after acquiring an additional 107,485 shares during the last quarter. Finally, Brant Point Investment Management LLC acquired a new stake in Phibro Animal Health during the 1st quarter worth approximately $2,216,000. Institutional investors and hedge funds own 99.34% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on PAHC shares. Weiss Ratings reissued a “buy (b-)” rating on shares of Phibro Animal Health in a report on Monday. Zacks Research lowered shares of Phibro Animal Health from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 10th. Morgan Stanley set a $34.00 price objective on shares of Phibro Animal Health in a research note on Thursday, August 28th. JPMorgan Chase & Co. raised their target price on shares of Phibro Animal Health from $45.00 to $50.00 and gave the stock an “overweight” rating in a research note on Friday, November 7th. Finally, Bank of America lifted their target price on shares of Phibro Animal Health from $19.00 to $27.00 and gave the company an “underperform” rating in a report on Friday, August 29th. Two equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $31.40.

Insider Transactions at Phibro Animal Health

In other Phibro Animal Health news, CEO Jack Bendheim sold 5,280 shares of the firm’s stock in a transaction on Wednesday, November 26th. The stock was sold at an average price of $44.02, for a total transaction of $232,425.60. Following the completion of the transaction, the chief executive officer owned 33,840 shares of the company’s stock, valued at approximately $1,489,636.80. This trade represents a 13.50% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Over the last 90 days, insiders sold 157,096 shares of company stock valued at $6,762,621. 50.13% of the stock is currently owned by corporate insiders.

Phibro Animal Health Trading Down 0.2%

Shares of PAHC stock opened at $40.68 on Wednesday. Phibro Animal Health Corporation has a fifty-two week low of $16.16 and a fifty-two week high of $46.42. The stock has a market cap of $1.65 billion, a P/E ratio of 34.47, a P/E/G ratio of 1.24 and a beta of 0.81. The business has a fifty day simple moving average of $41.08 and a 200-day simple moving average of $33.74. The company has a quick ratio of 1.25, a current ratio of 2.76 and a debt-to-equity ratio of 2.46.

Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings data on Wednesday, November 5th. The company reported $0.73 EPS for the quarter, topping the consensus estimate of $0.58 by $0.15. Phibro Animal Health had a net margin of 3.73% and a return on equity of 32.14%. The business had revenue of $363.89 million for the quarter, compared to analyst estimates of $345.44 million. Phibro Animal Health has set its FY 2026 guidance at 2.640-2.810 EPS. On average, analysts forecast that Phibro Animal Health Corporation will post 1.95 earnings per share for the current fiscal year.

Phibro Animal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 17th. Investors of record on Wednesday, November 26th will be given a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a dividend yield of 1.2%. The ex-dividend date is Wednesday, November 26th. Phibro Animal Health’s payout ratio is currently 28.92%.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.